Globavir Biosciences

Share on: 

Globavir is using  drug repurposing for treating global infectious diseases. Their lead drug candidate, GBV-006 is a combination of two FDA approved drugs and has shown efficacy in both in vitro as well as in vivo disease models affecting both viral load and mortality.

Los Altos CA
United States